1. Home
  2. NRXP vs RGS Comparison

NRXP vs RGS Comparison

Compare NRXP & RGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • RGS
  • Stock Information
  • Founded
  • NRXP 2015
  • RGS 1922
  • Country
  • NRXP United States
  • RGS United States
  • Employees
  • NRXP N/A
  • RGS N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • RGS Other Consumer Services
  • Sector
  • NRXP Health Care
  • RGS Consumer Discretionary
  • Exchange
  • NRXP Nasdaq
  • RGS Nasdaq
  • Market Cap
  • NRXP 51.3M
  • RGS 54.5M
  • IPO Year
  • NRXP N/A
  • RGS 1991
  • Fundamental
  • Price
  • NRXP $2.28
  • RGS $21.61
  • Analyst Decision
  • NRXP Strong Buy
  • RGS
  • Analyst Count
  • NRXP 3
  • RGS 0
  • Target Price
  • NRXP $31.67
  • RGS N/A
  • AVG Volume (30 Days)
  • NRXP 464.9K
  • RGS 33.6K
  • Earning Date
  • NRXP 03-27-2025
  • RGS 02-12-2025
  • Dividend Yield
  • NRXP N/A
  • RGS N/A
  • EPS Growth
  • NRXP N/A
  • RGS N/A
  • EPS
  • NRXP N/A
  • RGS 40.46
  • Revenue
  • NRXP N/A
  • RGS $191,336,000.00
  • Revenue This Year
  • NRXP N/A
  • RGS N/A
  • Revenue Next Year
  • NRXP N/A
  • RGS N/A
  • P/E Ratio
  • NRXP N/A
  • RGS $0.59
  • Revenue Growth
  • NRXP N/A
  • RGS N/A
  • 52 Week Low
  • NRXP $1.10
  • RGS $3.87
  • 52 Week High
  • NRXP $7.33
  • RGS $35.50
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 38.85
  • RGS 42.67
  • Support Level
  • NRXP $2.80
  • RGS $23.32
  • Resistance Level
  • NRXP $3.07
  • RGS $24.45
  • Average True Range (ATR)
  • NRXP 0.29
  • RGS 1.86
  • MACD
  • NRXP -0.10
  • RGS -0.29
  • Stochastic Oscillator
  • NRXP 2.52
  • RGS 13.68

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About RGS Regis Corporation

Regis Corp owns, franchises, and operates beauty salons throughout North America and the United Kingdom. The company's locations provide salon products and services to the mass market, including haircutting, styling, and hair coloring. The vast majority of Regis' salons are in strip malls, shopping centers, and Wal-Mart stores in North America and serve price-conscious customers. The company derives the majority of its revenue from these locations. The sale of products also contributes a relatively significant percentage of total sales. Regis also operates a smaller portfolio of premium salons across North America and the U.K. The company's majority brands include SmartStyle, Cost Cutters, and Supercuts.

Share on Social Networks: